Moderna preps for a private, more expensive Covid-19 vaccine market as Biden admin frets over unintentional shift
Members of Congress on both sides of the aisle still can’t come to an agreement on funds for new Covid-19 vaccine and treatments, and now both Moderna and the Biden administration signaled Thursday that they’re readying for the Covid-19 vaccine market to turn private, potentially as soon as later this year.
Any halt to government payments for Covid-19 vaccines will spell the end of free Covid-19 vaccines for all, and likely mean higher prices as the government would no longer be negotiating.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 150,400+ biopharma pros reading Endpoints daily — and it's free.